PhillyInc http://www.philly.com/philly/blogs/phillyinc RSS Feed for Inq Blogs PhillyInc en-us Fri, 06 Nov 2009 15:43:12 GMT Cigna will keep its PBM business http://www.philly.com/philly/blogs/phillyinc/Cigna_will_keep_its_PBM_business.html After evaluating options since the spring, the Philadelphia insurer decided against selling its pharmacy-benefits management unit. Biggest cost from SEPTA strike is time lost http://www.philly.com/philly/blogs/phillyinc/Biggest_cost_from_SEPTA_strike_is_time_lost.html Calculating the economic impact from the mass-transit strike is debatable, but the cost can be measured in time lost. Merck is 2nd-largest drug company ... for now http://www.philly.com/philly/blogs/phillyinc/Merck_is_2nd-largest_drug_company__for_now.html Mega-mergers have been shuffling the upper ranks of the pharmaceutical business. Treasury ups rates on savings bonds http://www.philly.com/philly/blogs/phillyinc/Treasury_ups_rates_on_savings_bonds.html Small investors were dismayed when the Series I bond rate fell to zero in May. Will they cheer 3.36 percent now? Innovation education at Weiss Tech House is spawning new companies http://www.philly.com/philly/blogs/phillyinc/Innovation_education_at_Weiss_Tech_House_is_spawning_new_companies.html The student-run organization helps University of Pennsylvania students learn how to turn ideas into products. Some of those products are the basis of new companies. Hartford's Froehlich sees the Dow surpassing 11,000 by year's end http://www.philly.com/philly/blogs/phillyinc/Hartfords_Froehlich_sees_the_Dow_surpassing_11000_by_years_end.html Probably the most bullish strategist lists five reasons why he thinks stocks head higher and two pitfalls that could cloud his forecast. GlaxoSmithKline sees sales rising in emerging markets http://www.philly.com/philly/blogs/phillyinc/GlaxoSmithKline_sees_sales_rising_in_emerging_markets.html The strategy of CEO Andrew Witty is reflected in the most recent quarterly results as Europe and the U.S. account for a smaller percentage of overall sales. Cephalon picks up one executive from Wyeth http://www.philly.com/philly/blogs/phillyinc/Cephalon_picks_up_one_executive_from_Wyeth.html Bob Repella becomes senior VP for Cephalon's U.S. pharmaceutical operations after 16 years at Wyeth. Triumph Group CEO: Phillies ready to repeat http://www.philly.com/philly/blogs/phillyinc/Triumph_Group_CEO_Phillies_ready_to_repeat.html The head of the Wayne aerospace company showed his true colors on an earnings call with analysts. Westwood Holdings to acquire Philadelphia Fund http://www.philly.com/philly/blogs/phillyinc/Westwood_Holdings_to_acquire_Philadelphia_Fund.html Shareholders of the tiny mutual fund, started in Philadelphia in the '20s, will vote on a deal Nov. 6 under which a Westwood fund will absorb its $50 million in assets.